Literature DB >> 12532470

Effects of time interval for hemofiltration on the prognosis of severe acute pancreatitis.

En-Qiang Mao1, Yao-Qing Tang, Sheng-Dao Zhang.   

Abstract

AIM: To evaluate the impact of time interval for hemofiltration (HF) on the prognosis of severe acute pancreatitis (SAP).
METHODS: Thirty-six consecutive patients with severe acute pancreatitis were included in the study. Atlanta classification system was applied for stratification. They were randomly divided into short veno-venous HF group, (SVVH, Group 1, 20 patients); and long veno-venous HF group (LVVH, Group 2, 16 patients). In group 1, SVVH was stopped when the abdominal signs disappeared, and heart rate and breath rate were less than 90 beats/min and 20 times/min, respectively. HF was stopped if SVVH was continued, and when heart rate and breath rate were more than 90 beats/min and 20 times/min again (Group 2). Except that the time interval for HF was different, other parameters for HF were the same. And conservative curing rate, survival rate, cost for hospital stay and length of hospital stay were observed.
RESULTS: Time interval for HF in Group 1 (3.81+/-1.3 hr) was shorter than that of in Group 2 (9.38+/-2.9 hr), P<0.01. Conservative curing rate (90 %) in Group 1 was much higher than that in Group 2 (56.3 %) (P<0.05); but cost in Group 1 (RMB 56 600+/-56 400 Yuan) was lower than that in Group 2 (RMB 137 000+/-105 000 Yuan) (P<0.05). And the survival rate (95 %) in Group 1 was higher than that in Group 2 (81.3 %) (P<0.25); however, hospital stay in Group 1 (44.3+/-41 days) was shorter than that in Group 2 (55.2+/-39.5 days) (P<0.2). So, the prognosis was not improved through the prolongation of time interval for HF, but side-effects were seen.
CONCLUSION: The prognosis was not further improved by LVVH in the treatment of SAP, with side-effects. Time interval for HF plays an important role in treatment of SAP in early stage. SVVH is thought to be superior to LVVH; and LVVH is superior to CVVH in early (72 hrs) treatment of SAP.

Entities:  

Mesh:

Year:  2003        PMID: 12532470      PMCID: PMC4611350          DOI: 10.3748/wjg.v9.i2.373

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  38 in total

1.  Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice.

Authors:  J L Van Laethem; R Eskinazi; H Louis; F Rickaert; P Robberecht; J Devière
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

2.  Role of cytokines and their inhibitors in acute pancreatitis.

Authors:  A Kingsnorth
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

3.  The soluble interleukin-2 receptor, peripheral blood, and reticulocyte fractions in acute pancreatitis.

Authors:  T Salomone; P Boni; C Serra; A M Morselli-Labate; A L Di Gioia; M Romboli; A Guariento
Journal:  Int J Pancreatol       Date:  1996-12

4.  Therapy of microcirculatory disorders in severe acute pancreatitis: what mediators should we block?

Authors:  Guido Eibl; Heinz J Buhr; Thomas Foitzik
Journal:  Intensive Care Med       Date:  2002-01-17       Impact factor: 17.440

5.  Profiles of pro-inflammatory cytokines in the serum of rabbits after experimentally induced acute pancreatitis.

Authors:  Maher O Osman; Borbala Gesser; Janne T Mortensen; Kouji Matsushima; Steen L Jensen; Christian G Larsen
Journal:  Cytokine       Date:  2002-01-07       Impact factor: 3.861

6.  Use of extracorporeal supportive techniques as additional treatment for septic-induced multiple organ failure patients.

Authors:  E Barzilay; D Kessler; G Berlot; A Gullo; D Geber; I Ben Zeev
Journal:  Crit Care Med       Date:  1989-07       Impact factor: 7.598

7.  Continuous arteriovenous hemofiltration attenuates polymorphonuclear leukocyte phagocytosis in porcine intra-abdominal sepsis.

Authors:  A W DiScipio; K W Burchard
Journal:  Am J Surg       Date:  1997-03       Impact factor: 2.565

8.  Continuous regional application of protease inhibitor in the treatment of acute pancreatitis. An experimental study using closed duodenal obstruction model in dogs.

Authors:  J Yamauchi; K Takeda; K Shibuya; M Sunamura; S Matsuno
Journal:  Pancreatology       Date:  2001       Impact factor: 3.996

9.  Inhibition of TNF alpha improves survival in an experimental model of acute pancreatitis.

Authors:  C B Hughes; L W Gaber; A B Mohey el-Din; H P Grewal; M Kotb; L Mann; A O Gaber
Journal:  Am Surg       Date:  1996-01       Impact factor: 0.688

Review 10.  Evaluation of factors that have reduced mortality from acute pancreatitis over the past 20 years.

Authors:  Simmy Bank; Pankaj Singh; Nakechand Pooran; Bernard Stark
Journal:  J Clin Gastroenterol       Date:  2002-07       Impact factor: 3.062

View more
  9 in total

1.  Conservative approach in the management of severe acute pancreatitis: eight-year experience in a single institution.

Authors:  G Pupelis; K Zeiza; H Plaudis; A Suhova
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

Review 2.  Fluid resuscitation in acute pancreatitis.

Authors:  Aakash Aggarwal; Manish Manrai; Rakesh Kochhar
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

3.  Sequential blood purification therapy for critical patients with hyperlipidemic severe acute pancreatitis.

Authors:  Hong-Liang Wang; Kai-Jiang Yu
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

4.  Clinical study on nutrition support in patients with severe acute pancreatitis.

Authors:  Gang Zhao; Chun-You Wang; Fang Wang; Jiong-Xin Xiong
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

5.  Continuous veno-venous haemofiltration in the treatment of severe acute pancreatitis: 6-year experience.

Authors:  G Pupelis; H Plaudis; A Grigane; K Zeiza; G Purmalis
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

6.  Cost-effectiveness analysis of early veno-venous hemofiltration for severe acute pancreatitis in China.

Authors:  Kun Jiang; Xin-Zu Chen; Qing Xia; Wen-Fu Tang; Lei Wang
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

7.  Formalized therapeutic guideline for hyperlipidemic severe acute pancreatitis.

Authors:  En-Qiang Mao; Yao-Qing Tang; Sheng-Dao Zhang
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

8.  Organ failure associated with severe acute pancreatitis.

Authors:  Ai-Jun Zhu; Jing-Sen Shi; Xue-Jun Sun
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

9.  Organ failure associated with acute pancreatitis in African-American and Hispanic patients.

Authors:  Magda A Shaheen; Abbasi J Akhtar
Journal:  J Natl Med Assoc       Date:  2007-12       Impact factor: 1.798

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.